Company intelligence / Profile preview

Theras Group

Ownership: Private
Development stage: Commercial

Overview

Theras Group is an Italian healthcare technology company focused on developing advanced solutions for managing chronic diseases such as diabetes, chronic pain, and obesity. The group emphasizes innovation in medical devices and digital health to improve patient care and quality of life. Their approach combines next-generation technologies with ongoing support for patients and caregivers.

Therapeutic areas: EndocrinologyNeurology
Modalities: DeviceDigital health solutionsMedical technology platforms
Industry: Digital Health Medical Devices

Drug pipeline

2 assets

Plenity

Commercial

Indications: Weight management

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Theras Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Theras Group.

Explore the full profile